Hayrettin Guven

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(8):E1413-E1421
RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo
Alkasalias T; Alexeyenko A; Hennig K; Danielsson F; Lebbink RJ; Fielden M; Turunen SP; Lehti K; Kashuba V; Madapura HS; Bozoky B; Lundberg E; Balland M; Guven H; Klein G; Gad AKB; Pavlova T
Article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2015;34(1):62
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth
Alexeyenko A; Alkasalias T; Pavlova T; Szekely L; Kashuba V; Rundqvist H; Wiklund P; Egevad L; Csermely P; Korcsmaros T; Guven H; Klein G
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(48):17188-17193
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent
Alkasalias T; Flaberg E; Kashuba V; Alexeyenko A; Pavlova T; Savchenko A; Szekely L; Klein G; Guven H
Article: CANCER MEDICINE. 2014;3(3):485-491
Decreased decorin expression in the tumor microenvironment
Bozoky B; Savchenko A; Guven H; Ponten F; Klein G; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(10):2274-2283
The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth
Flaberg E; Guven H; Savchenko A; Pavlova T; Kashuba V; Szekely L; Klein G
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(33):13231-13236
Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan
Cheng H-H; Kuo C-C; Yan J-L; Chen H-L; Lin W-C; Wang K-H; Tsai KK-C; Guven H; Flaberg E; Szekely L; Klein G; Wu KK
Article: IMMUNOTHERAPY. 2009;1(5):753-764
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
Barkholt L; Alici E; Conrad R; Sutlu T; Gilljam M; Stellan B; Christensson B; Guven H; Bjorkstrom NK; Soderdahl G; Cederlund K; Kimby E; Aschan J; Ringden O; Ljunggren H-G; Dilber MS
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2009;145(6):749-760
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study
Ingram W; Chan L; Guven H; Darling D; Kordasti S; Hardwick N; Barber L; Mufti GJ; Farzaneh F
Article: LEUKEMIA. 2006;20(5):833-839
Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice
Guimaraes F; Guven H; Donati D; Christensson B; Ljunggren HG; Bejarano MT; Dilber MS
Article: EXPERIMENTAL HEMATOLOGY. 2005;33(11):1320-1328
Efficient gene transfer into primary human natural killer cells by retroviral transduction
Guven H; Konstantinidis KV; Alici E; Aints A; Abedi-Valugerdi M; Christensson B; Ljunggren HG; Dilber MS
Article: LEUKEMIA. 2003;17(10):1973-1980
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Article: HUMAN GENE THERAPY. 2002;13(8):969-977
Enhanced ouabain resistance gene as a eukaryotic selection marker
Aints A; Belusa R; Andersson RM; Güven H; Dilber MS
Article: HUMAN IMMUNOLOGY. 2001;62(10):1092-1098
A new method for in vitro expansion of cytotoxic human CD3^-CD56⁺ natural killer cells
Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
Article: GENE THERAPY. 2001;8(14):1051-1056
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting
Aints A; Güven H; Gahrton G; Smith CIE; Dilber MS

Alla övriga publikationer

Meeting abstract: CLINICAL LYMPHOMA AND MYELOMA. 2009;9:s135-s136
NK Cell-Mediated Immunologic Responses Against Myeloma by B7-1 (CD80)/IL-2 Immune Gene Therapy
Guven H; Chan L; Darling D; Schey S; Mufti G; Farzaneh F
Thesis / dissertation: 2005
The therapeutic potential of ex vivo expanded natural killer (NK) cells for immunotherapy of cancer
Guven, Hayrettin

Anställningar

Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2027
Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2024-2026

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Huddinge, Karolinska Institutet, 2005

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI